Cite

HARVARD Citation

    Pappas, D. et al. (2014). AB0379 Laboratory Safety of Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Rheumatoid Arthritis. Annals of the rheumatic diseases. p. 931. [Online]. 
  
Back to record